A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension
一项随机、双盲、安慰剂对照的IIa期临床研究，旨在探讨SPH3127片剂治疗原发性高血压患者的疗效和安全性。
期刊:Hypertension Research
影响因子:4.6
doi:10.1038/s41440-024-01657-z
Wang, Fang; Liu, Ling; Ruan, Hongyun; Chen, Xiaoping; Zhang, Yue; Yu, Zaixin; Li, Yuhui; Guan, Yang; Wang, Jiguang; Huang, Kai; Yu, Shunjiang; Cao, Yuanyuan; Ding, Cungang; Chang, Lin; Huang, Yaohua; Chen, Xiangjuan; Lv, Qiang; Ma, Changsheng
